Lentiviral marking of patient-derived acute lymphoblastic leukaemic cells allows in vivo tracking of disease progression

S. Bomken; L. Buechler; K. Rehe; F. Ponthan; A. Elder; H. Blair; C. M. Bacon; J. Vormoor; O. Heidenreich

doi:10.1038/leu.2012.206

Lentiviral marking of patient-derived acute lymphoblastic leukaemic cells allows in vivo tracking of disease progression

S. Bomken, L. Buechler, K. Rehe, F. Ponthan, A. Elder, H. Blair, C. M. Bacon, J. Vormoor, O. Heidenreich

Onderzoeksoutput: Bijdrage aan tijdschrift › Brief › peer review

25 Citaten (Scopus)

Originele taal-2	Engels
Pagina's (van-tot)	718-721
Aantal pagina's	4
Tijdschrift	Leukemia
Volume	27
Nummer van het tijdschrift	3
DOI's	https://doi.org/10.1038/leu.2012.206
Status	Gepubliceerd - mrt. 2013
Extern gepubliceerd	Ja

Toegang tot document

10.1038/leu.2012.206

Citeer dit

@article{f2ece64c93d541da95cc26c82df749e6,

title = "Lentiviral marking of patient-derived acute lymphoblastic leukaemic cells allows in vivo tracking of disease progression",

author = "S. Bomken and L. Buechler and K. Rehe and F. Ponthan and A. Elder and H. Blair and Bacon, {C. M.} and J. Vormoor and O. Heidenreich",

note = "Funding Information: We thank Christopher Baum and Olga Kustikova for their help with the ligation-mediated PCR and Martin Stanulla and Martin Schrappe for the provision of sample L4951. SB is funded by a Medical Research Council (MRC) Clinical Research Training Fellowship. The IVIS Spectrum was funded by a grant from the Wellcome Trust, grant 087961. Additional funding came from Leukaemia Lymphoma Research (LLR) and core infrastructure support from the North of England Children′s Cancer Research Fund (NECCR).",

year = "2013",

month = mar,

doi = "10.1038/leu.2012.206",

language = "English",

volume = "27",

pages = "718--721",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "3",

}

TY - JOUR

T1 - Lentiviral marking of patient-derived acute lymphoblastic leukaemic cells allows in vivo tracking of disease progression

AU - Bomken, S.

AU - Buechler, L.

AU - Rehe, K.

AU - Ponthan, F.

AU - Elder, A.

AU - Blair, H.

AU - Bacon, C. M.

AU - Vormoor, J.

AU - Heidenreich, O.

N1 - Funding Information: We thank Christopher Baum and Olga Kustikova for their help with the ligation-mediated PCR and Martin Stanulla and Martin Schrappe for the provision of sample L4951. SB is funded by a Medical Research Council (MRC) Clinical Research Training Fellowship. The IVIS Spectrum was funded by a grant from the Wellcome Trust, grant 087961. Additional funding came from Leukaemia Lymphoma Research (LLR) and core infrastructure support from the North of England Children′s Cancer Research Fund (NECCR).

PY - 2013/3

Y1 - 2013/3

UR - http://www.scopus.com/inward/record.url?scp=84875231419&partnerID=8YFLogxK

U2 - 10.1038/leu.2012.206

DO - 10.1038/leu.2012.206

M3 - Letter

C2 - 22858908

AN - SCOPUS:84875231419

SN - 0887-6924

VL - 27

SP - 718

EP - 721

JO - Leukemia

JF - Leukemia

IS - 3

ER -